166 related articles for article (PubMed ID: 37576871)
1. Tumor-targeted liposomes with platycodin D2 promote apoptosis in colorectal cancer.
Cho E; Mun SJ; Jeon M; Kim HK; Baek H; Ham YS; Gil WJ; Kim JW; Yang CS
Mater Today Bio; 2023 Oct; 22():100745. PubMed ID: 37576871
[TBL] [Abstract][Full Text] [Related]
2. Tumor targeting using anti-her2 immunoliposomes.
Park JW; Kirpotin DB; Hong K; Shalaby R; Shao Y; Nielsen UB; Marks JD; Papahadjopoulos D; Benz CC
J Control Release; 2001 Jul; 74(1-3):95-113. PubMed ID: 11489487
[TBL] [Abstract][Full Text] [Related]
3. In vitro comparison of liposomal drug delivery systems targeting the oxytocin receptor: a potential novel treatment for obstetric complications.
Hua S; Vaughan B
Int J Nanomedicine; 2019; 14():2191-2206. PubMed ID: 30988616
[TBL] [Abstract][Full Text] [Related]
4. Dual drug loaded liposome bearing apigenin and 5-Fluorouracil for synergistic therapeutic efficacy in colorectal cancer.
Sen K; Banerjee S; Mandal M
Colloids Surf B Biointerfaces; 2019 Aug; 180():9-22. PubMed ID: 31015105
[TBL] [Abstract][Full Text] [Related]
5. Liposome technologies towards colorectal cancer therapeutics.
Sang R; Stratton B; Engel A; Deng W
Acta Biomater; 2021 Jun; 127():24-40. PubMed ID: 33812076
[TBL] [Abstract][Full Text] [Related]
6. An ATF
Zhai B; Chen P; Wang W; Liu S; Feng J; Duan T; Xiang Y; Zhang R; Zhang M; Han X; Chen X; Li Q; Li G; Liu Y; Huang X; Zhang W; Pan T; Yan L; Jin T; Xie T; Sui X
Cancer Biol Med; 2020 Aug; 17(3):676-692. PubMed ID: 32944399
[No Abstract] [Full Text] [Related]
7. One Stone Four Birds: A Novel Liposomal Delivery System Multi-functionalized with Ginsenoside Rh2 for Tumor Targeting Therapy.
Hong C; Liang J; Xia J; Zhu Y; Guo Y; Wang A; Lu C; Ren H; Chen C; Li S; Wang D; Zhan H; Wang J
Nanomicro Lett; 2020 Jun; 12(1):129. PubMed ID: 34138128
[TBL] [Abstract][Full Text] [Related]
8. Targeted delivery of irinotecan to colon cancer cells using epidermal growth factor receptor-conjugated liposomes.
Liu Y; Li X; Pen R; Zuo W; Chen Y; Sun X; Gou J; Guo Q; Wen M; Li W; Yu S; Liu H; Huang M
Biomed Eng Online; 2022 Aug; 21(1):53. PubMed ID: 35918704
[TBL] [Abstract][Full Text] [Related]
9. Lactoferrin-Modified Gambogic Acid Liposomes for Colorectal Cancer Treatment.
Wang R; Qu J; Tang X; Zhang J; Ou A; Li Q; Chen G; Zheng C; Muhitdinov B; Huang Y
Mol Pharm; 2023 Aug; 20(8):3925-3936. PubMed ID: 37505210
[TBL] [Abstract][Full Text] [Related]
10. Cyclic RGD peptide-modified liposomal drug delivery system for targeted oral apatinib administration: enhanced cellular uptake and improved therapeutic effects.
Song Z; Lin Y; Zhang X; Feng C; Lu Y; Gao Y; Dong C
Int J Nanomedicine; 2017; 12():1941-1958. PubMed ID: 28331317
[TBL] [Abstract][Full Text] [Related]
11. Mechanistic insights into the pH-dependent membrane peptide ATRAM.
Nguyen VP; Palanikumar L; Kennel SJ; Alves DS; Ye Y; Wall JS; Magzoub M; Barrera FN
J Control Release; 2019 Mar; 298():142-153. PubMed ID: 30763623
[TBL] [Abstract][Full Text] [Related]
12. A novel tumor-homing TRAIL variant eradicates tumor xenografts of refractory colorectal cancer cells in combination with tumor cell-targeted photodynamic therapy.
Li Z; She T; Yang H; Su T; Shi Q; Tao Z; Feng Y; Yang F; Cheng J; Lu X
Drug Deliv; 2022 Dec; 29(1):1698-1711. PubMed ID: 35635308
[TBL] [Abstract][Full Text] [Related]
13. Tumor-targeting, systemically delivered antisense HER-2 chemosensitizes human breast cancer xenografts irrespective of HER-2 levels.
Rait AS; Pirollo KF; Xiang L; Ulick D; Chang EH
Mol Med; 2002 Aug; 8(8):475-86. PubMed ID: 12435858
[TBL] [Abstract][Full Text] [Related]
14. Cetuximab-oxaliplatin-liposomes for epidermal growth factor receptor targeted chemotherapy of colorectal cancer.
Zalba S; Contreras AM; Haeri A; Ten Hagen TL; Navarro I; Koning G; Garrido MJ
J Control Release; 2015 Jul; 210():26-38. PubMed ID: 25998052
[TBL] [Abstract][Full Text] [Related]
15. Bispecific antibody (HER2 × mPEG) enhances anti-cancer effects by precise targeting and accumulation of mPEGylated liposomes.
Chen IJ; Cheng YA; Ho KW; Lin WW; Cheng KW; Lu YC; Hsieh YC; Huang CC; Chuang CH; Chen FM; Su YC; Roffler SR; Cheng TL
Acta Biomater; 2020 Jul; 111():386-397. PubMed ID: 32417267
[TBL] [Abstract][Full Text] [Related]
16. Co-delivery of 5-fluorouracil and miRNA-34a mimics by host-guest self-assembly nanocarriers for efficacious targeted therapy in colorectal cancer patient-derived tumor xenografts.
Xu J; Zhang G; Luo X; Wang D; Zhou W; Zhang Y; Zhang W; Chen J; Meng Q; Chen E; Chen H; Song Z
Theranostics; 2021; 11(5):2475-2489. PubMed ID: 33500737
[No Abstract] [Full Text] [Related]
17. Opportunities and challenges for co-delivery nanomedicines based on combination of phytochemicals with chemotherapeutic drugs in cancer treatment.
Gao Q; Feng J; Liu W; Wen C; Wu Y; Liao Q; Zou L; Sui X; Xie T; Zhang J; Hu Y
Adv Drug Deliv Rev; 2022 Sep; 188():114445. PubMed ID: 35820601
[TBL] [Abstract][Full Text] [Related]
18. Enhanced tumor accumulation and therapeutic efficacy of liposomal drugs through over-threshold dosing.
Ao H; Wang Z; Lu L; Ma H; Li H; Fu J; Li M; Han M; Guo Y; Wang X
J Nanobiotechnology; 2022 Mar; 20(1):137. PubMed ID: 35292036
[TBL] [Abstract][Full Text] [Related]
19. Focused ultrasound and interleukin-4 receptor-targeted liposomal doxorubicin for enhanced targeted drug delivery and antitumor effect in glioblastoma multiforme.
Yang FY; Wong TT; Teng MC; Liu RS; Lu M; Liang HF; Wei MC
J Control Release; 2012 Jun; 160(3):652-8. PubMed ID: 22405901
[TBL] [Abstract][Full Text] [Related]
20. Liposome-based co-delivery of siRNA and docetaxel for the synergistic treatment of lung cancer.
Qu MH; Zeng RF; Fang S; Dai QS; Li HP; Long JT
Int J Pharm; 2014 Oct; 474(1-2):112-22. PubMed ID: 25138252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
